New Breast Cancer Treatment Could Be A Game Changer
Newsy
Right now, the five-year survival rate for people with metastatic breast cancer is just 27%. But ErSO eliminated cancer in mice in just seven days.
At the University of Illinois, biochemists study "ErSO " — a compound that could be a game changer for the thousands of patients and their loved ones devastated by breast cancer every year.
Lindsey Theis: "Is it fair to call it a breast cancer breakthrough?"
ErSO researcher Darjan Duraki: "I think right now has the potential to be a breakthrough."
More Related News